Our failure to advance new treatments for glioma to market.
Publication
, Journal Article
Sampson, JH; Kaminski, TJ; Schulman, KA
Published in: J Neurosurg
August 2011
Duke Scholars
Published In
J Neurosurg
DOI
EISSN
1933-0693
Publication Date
August 2011
Volume
115
Issue
2
Start / End Page
245 / 247
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- Male
- Humans
- Glioblastoma
- Female
- Cancer Vaccines
- Brain Neoplasms
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sampson, J. H., Kaminski, T. J., & Schulman, K. A. (2011). Our failure to advance new treatments for glioma to market. J Neurosurg, 115(2), 245–247. https://doi.org/10.3171/2010.11.JNS101436
Sampson, John H., Thomas J. Kaminski, and Kevin A. Schulman. “Our failure to advance new treatments for glioma to market.” J Neurosurg 115, no. 2 (August 2011): 245–47. https://doi.org/10.3171/2010.11.JNS101436.
Sampson JH, Kaminski TJ, Schulman KA. Our failure to advance new treatments for glioma to market. J Neurosurg. 2011 Aug;115(2):245–7.
Sampson, John H., et al. “Our failure to advance new treatments for glioma to market.” J Neurosurg, vol. 115, no. 2, Aug. 2011, pp. 245–47. Pubmed, doi:10.3171/2010.11.JNS101436.
Sampson JH, Kaminski TJ, Schulman KA. Our failure to advance new treatments for glioma to market. J Neurosurg. 2011 Aug;115(2):245–247.
Published In
J Neurosurg
DOI
EISSN
1933-0693
Publication Date
August 2011
Volume
115
Issue
2
Start / End Page
245 / 247
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- Male
- Humans
- Glioblastoma
- Female
- Cancer Vaccines
- Brain Neoplasms
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences